These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9203648)

  • 21. Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.
    Nichols CN; Bernal I; Prince AM; Andrus L
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):49-56. PubMed ID: 11804556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of HIV infection by passive immunization with HIV immunoglobulin.
    Prince AM; Reesink H; Pascual D; Horowitz B; Hewlett I; Murthy KK; Cobb KE; Eichberg JW
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):971-3. PubMed ID: 1812946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. For the Women and Infants Transmission Study.
    Pitt J; Henrard D; FitzGerald G; Mofenson L; Lew J; Hillyer G; Mendez H; Cooper E; Hanson C; Rich KC
    J Infect Dis; 2000 Oct; 182(4):1243-6. PubMed ID: 10979926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between human immunodeficiency virus-1 RNA identification in placenta and perinatal transmission.
    Katz JM; Fox CH; Eglinton GS; Meyers WA; Queenan JT
    J Perinatol; 1997; 17(2):119-24. PubMed ID: 9134510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The amount of early p24 antigenemia and not the time of first detection of virus predicts the clinical outcome of infants vertically infected with human immunodeficiency virus.
    Papaevangelou V; Pollack H; Riguad M; Arlievsky N; Lu ML; Rochford G; Krasinski K; Borkowsky W
    J Infect Dis; 1996 Mar; 173(3):574-8. PubMed ID: 8627019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
    N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double-blind controlled trial. The Passive Hyperimmune Therapy Study Group.
    Levy J; Youvan T; Lee ML
    Blood; 1994 Oct; 84(7):2130-5. PubMed ID: 7919326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
    Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
    New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of HIV-1 cell-free viremia.
    Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
    JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of HIV-1 p24 antibody expressed as relative binding capacity p24 antigen (p24 RBC) in infants born to HIV-1 seropositive mothers: correlation of this serological marker with the HIV-1 maternal antibody course and p24 antigenemia detection.
    Portolani M; Meacci M; Pecorari M; Pietrosemoli P; Cermelli C; Cellini M; Tampieri A; Tartoni P; Stella F
    Viral Immunol; 1995; 8(2):93-9. PubMed ID: 8825294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors.
    Backé E; Jimenez E; Unger M; Schäfer A; Vocks-Hauck M; Grosch-Wörner I; Vogel M
    Am J Perinatol; 1994 Sep; 11(5):326-30. PubMed ID: 7993509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group.
    Burgard M; Mayaux MJ; Blanche S; Ferroni A; Guihard-Moscato ML; Allemon MC; Ciraru-Vigneron N; Firtion G; Floch C; Guillot F
    N Engl J Med; 1992 Oct; 327(17):1192-7. PubMed ID: 1406792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer.
    Pancino G; Leste-Lasserre T; Burgard M; Costagliola D; Ivanoff S; Blanche S; Rouzioux C; Sonigo P
    J Infect Dis; 1998 Jun; 177(6):1737-41. PubMed ID: 9607861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.
    Wright PF; Lambert JS; Gorse GJ; Hsieh RH; McElrath MJ; Weinhold K; Wara DW; Anderson EL; Keefer MC; Jackson S; Wagner LJ; Francis DP; Fast PE; McNamara J
    J Infect Dis; 1999 Oct; 180(4):1080-8. PubMed ID: 10479134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
    Bush CE; Donovan RM; Manzor O; Baxa D; Moore E; Cohen F; Saravolatz LD
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):11-5. PubMed ID: 8825613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    ; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
    AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.
    Mirochnick M; Fenton T; Gagnier P; Pav J; Gwynne M; Siminski S; Sperling RS; Beckerman K; Jimenez E; Yogev R; Spector SA; Sullivan JL
    J Infect Dis; 1998 Aug; 178(2):368-74. PubMed ID: 9697716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.